2016
DOI: 10.2147/rred.s96578
|View full text |Cite
|
Sign up to set email alerts
|

Pathophysiology and therapeutic options in osteogenesis imperfecta: an update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 99 publications
0
4
0
Order By: Relevance
“…Therefore, research in this area is important to provide patients with the best possible treatments. There are many reviews on the pre-clinical treatment strategies, but existing therapies for OI are mainly based on an intravenous administration of bisphosphonates, however, with undesirable side effects [25][26][27][50][51][52]. Long-term inhibition of osteoclasts by bisphosphonates may reduce bone quality, leading to non-dynamic bone in which microdamages are not repaired and accumulate, likely causing an overall increase in bone fragility [25,26].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Therefore, research in this area is important to provide patients with the best possible treatments. There are many reviews on the pre-clinical treatment strategies, but existing therapies for OI are mainly based on an intravenous administration of bisphosphonates, however, with undesirable side effects [25][26][27][50][51][52]. Long-term inhibition of osteoclasts by bisphosphonates may reduce bone quality, leading to non-dynamic bone in which microdamages are not repaired and accumulate, likely causing an overall increase in bone fragility [25,26].…”
Section: Discussionmentioning
confidence: 99%
“…Long-term inhibition of osteoclasts by bisphosphonates may reduce bone quality, leading to non-dynamic bone in which microdamages are not repaired and accumulate, likely causing an overall increase in bone fragility [25,26]. Unusual femoral fractures and delayed teeth eruption have been reported in children after longterm treatment with pamidronate [50].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Osteogenesis imperfecta (OI) is a rare inherited disorder caused mainly by mutations in the collagen genes COL1A1 or COL1A2 [34][35][36][37]. Collagen Type-I constitutes approximately 80% of human corneal collagen.…”
Section: Associated Genetic Disordersmentioning
confidence: 99%